These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 35989448)

  • 1. An early evaluation of the HISTO SPOT
    Cashin J; Flynn P; Worthington J; Lowe M; Canterbury A; Launhardt K; Crosby I; Sheldon S; Venkateswaran R; Poulton K
    Int J Immunogenet; 2022 Oct; 49(5):317-324. PubMed ID: 35989448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of HLA antibody identification methods for the selection of platelet products for HLA-mediated platelet refractory patients.
    Pedini P; Hubert L; Baudey JB; Etienne JM; Basire A; Vey N; Chiaroni J; Chabrières C; Ladaique P; Picard C
    HLA; 2024 Jan; 103(1):e15276. PubMed ID: 37947374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concordance with established tests and reproducibility of results obtained with a new single antigen chip array for HLA antibody detection (HISTO SPOT® HLA AB).
    Launhardt K; Lefevre V; Souplet V; Prantl L; Marget M; Hovoricova B; Wenda S; Olivier C
    J Immunol Methods; 2021 Apr; 491():112971. PubMed ID: 33549571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A modeling approach for mean fluorescence intensity value harmonization and cutoff prediction for luminex single antigen bead assays of two different vendors.
    Karahan GE; Haasnoot GW; Voogt-Bakker K; Claas FHJ; Roelen D; Heidt S
    HLA; 2023 Nov; 102(5):557-569. PubMed ID: 37130801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of Panel Reactive Antibodies in Renal Transplant Recipients Detected by Luminex: A Single-Center Experience.
    İnal A; Özçelik Ü; Ogan Uyanık E; Külah E; Demirağ A
    Exp Clin Transplant; 2016 Aug; 14(4):401-4. PubMed ID: 26517205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Most Common HLA Alleles and Anti-HLA Antibodies to Know for Virtual Cross-Match.
    Baştürk B; Kantaroğlu B; Kavuzlu M; Sarıtürk Ç
    Exp Clin Transplant; 2016 Nov; 14(Suppl 3):53-55. PubMed ID: 27805512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of Rapid Optimized 96-well Tray Flow Cytometric Crossmatch (Halifax-FCXM) with Luminex Single Antigen Test.
    Yoo J; Lee S; Lee HW; Lee S; Choi J; Han J; Kang H; Choi A; Hee Jang J; Oh EJ
    Hum Immunol; 2021 Apr; 82(4):302-308. PubMed ID: 33744026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation.
    Caro-Oleas JL; González-Escribano MF; González-Roncero FM; Acevedo-Calado MJ; Cabello-Chaves V; Gentil-Govantes MÁ; Núñez-Roldán A
    Nephrol Dial Transplant; 2012 Mar; 27(3):1231-8. PubMed ID: 21810767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Sensitivity of Immunocomplex Capture Fluorescence Analysis for Detecting Donor-specific Anti-HLA Class II Antibodies in Kidney Transplant Patients.
    Ichimaru N; Takayama T; Hirase H; Hisayama Y; Kawamura M; Nakazawa S; Kato T; Abe T; Kaimori JY; Imamura R; Nonomura N; Takahara S
    Transplant Proc; 2018 May; 50(4):1074-1076. PubMed ID: 29731068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human leukocyte antigen and major histocompatibility complex class I-related chain A antibodies after kidney transplantation in Turkish renal transplant recipients.
    Seyhun Y; Ozdilli K; Oguz F; Karahan G; Onal E; Turkmen A; Eldegez U; Nane I; Çalişkan Y; Bakkaloglu H; Carin M
    Transplant Proc; 2012; 44(6):1660-6. PubMed ID: 22841239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic Screening Using Luminex for De Novo C3d Fixing of Class II Donor-Specific Antibodies Is Correlated With Luminex Mean Fluorescence Intensity in Renal Transplant Patients.
    Villemaire M; Jouve T; Bourdin A; Janbon B; Pinel N; Tetaz R; Terrier N; Rostaing L; Masson D; Malvezzi P
    Exp Clin Transplant; 2019 Aug; 17(4):483-489. PubMed ID: 30346267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA class II donor specific antibodies are associated with graft cirrhosis after liver transplant independent of the mean fluorescence intensity level.
    Willuweit K; Frey A; Bieniek L; Heinold A; Büchter M; Horn PA; Wedemeyer H; Herzer K
    BMC Gastroenterol; 2020 Aug; 20(1):288. PubMed ID: 32854625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Technical Limitations of the C1q Single-Antigen Bead Assay to Detect Complement Binding HLA-Specific Antibodies.
    Taylor CJ; Kosmoliaptsis V; Martin J; Knighton G; Mallon D; Bradley JA; Peacock S
    Transplantation; 2017 Jun; 101(6):1206-1214. PubMed ID: 27306532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA graph, a free and ready-to-use bioinformatics tool to explore anti-HLA eplets reactivity pattern.
    Usureau C; Jacob V; Dubois V; Masson D; Jollet I; Desoutter J; Taupin JL; Guillaume N
    HLA; 2022 Sep; 100(3):244-253. PubMed ID: 35672253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of Complement-Binding Capacity of HLA Antibodies Based on Mean Fluorescence Intensity.
    Zhao J; Fu YX; Yang T; Shen ZY; Wu CL
    Transplant Proc; 2016; 48(6):2235-40. PubMed ID: 27569975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretransplantation monitoring of HLA antibodies by complement dependent cytotoxicity and Luminex-based assays.
    Katalinić N; Fućak M; Crnić T; Ćurković M; Starčević A; Balen S
    Wien Klin Wochenschr; 2017 Jan; 129(1-2):33-37. PubMed ID: 27743177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specificity of preformed alloantibodies causing B cell positive flow crossmatch in renal transplantation.
    Lobashevsky AL; Senkbeil RW; Shoaf J; Mink C; Rowe C; Lobashevsky ES; Burke R; Hudson S; Deierhoi MH; Thomas JM
    Clin Transplant; 2000 Dec; 14(6):533-42. PubMed ID: 11127305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The good, the bad, and the ugly of luminex donor-specific crossmatch.
    Chowdhry M; Makroo RN; Thakur Y; Sharma V; Singh M; Kumar M
    HLA; 2018 Jun; 91(6):501-506. PubMed ID: 29457879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of C3d assay and IgG subclass in the prediction of the flow cytometry cross-match result for renal transplantation.
    Contreras AG; Casillas-Abundis A; Alberú J; Llorente L; Lima G; Arvizu A; de Santiago A; Vilatobá M; Granados J; Morales-Buenrostro LE; Cruz R; Arreola-Guerra JM
    Transpl Immunol; 2018 Oct; 50():8-14. PubMed ID: 29885443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.